1,667 reports of this reaction
1.5% of all ACETAMINOPHEN AND CODEINE reports
#6 most reported adverse reaction
ARTHRALGIA is the #6 most commonly reported adverse reaction for ACETAMINOPHEN AND CODEINE, manufactured by Amneal Pharmaceuticals LLC. There are 1,667 FDA adverse event reports linking ACETAMINOPHEN AND CODEINE to ARTHRALGIA. This represents approximately 1.5% of all 113,152 adverse event reports for this drug.
Patients taking ACETAMINOPHEN AND CODEINE who experience arthralgia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ARTHRALGIA is a less commonly reported adverse event for ACETAMINOPHEN AND CODEINE, but still significant enough to appear in the safety profile.
In addition to arthralgia, the following adverse reactions have been reported for ACETAMINOPHEN AND CODEINE:
The following drugs have also been linked to arthralgia in FDA adverse event reports:
ARTHRALGIA has been reported as an adverse event in 1,667 FDA reports for ACETAMINOPHEN AND CODEINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ARTHRALGIA accounts for approximately 1.5% of all adverse event reports for ACETAMINOPHEN AND CODEINE, making it a notable side effect.
If you experience arthralgia while taking ACETAMINOPHEN AND CODEINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.